Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2012

Open Access 01-12-2012 | Case report

Locally advanced breast cancer made amenable to radical surgery after a combination of systemic therapy and Mohs paste: two case reports

Authors: Tomoya Tsukada, Tatsuo Nakano, Miki Matoba, Daisuke Matsui, Shozo Sasaki

Published in: Journal of Medical Case Reports | Issue 1/2012

Login to get access

Abstract

Introduction

Chemotherapy and other systemic therapies are the primary treatments for patients with unresectable, locally advanced breast cancer. The clinical application of supportive care using Mohs paste has become widespread for the purpose of improving patients’ quality of life. Here, we report two cases of locally advanced breast cancer, for which the patients underwent radical surgery after a combination of systemic therapy and Mohs chemosurgery.

Case presentations

Patient 1 was a 90-year-old Japanese woman with right breast cancer diagnosed as stage IIIB (T4bN1M0). The treatment included Mohs paste application and hormonal therapies. Patient 2 was a 60-year-old Japanese woman with right breast cancer diagnosed as stage IIIB (T4cN2aM0). Her treatment included Mohs paste application, together with chemotherapy (four cycles of 5-fluorouracil, epirubicin, and cyclophosphamide, and four cycles of docetaxel). In both cases, a reduction in the primary tumor volume was observed, and radical mastectomy and axillary lymph node dissection were possible without relaxation incision or skin flap.

Conclusion

We report patients with no distant metastases who were able to undergo radical resection after a combination of systemic therapy and Mohs chemosurgery. For locally advanced breast cancer, Mohs chemosurgery, in addition to multidisciplinary treatment, is useful.
Appendix
Available only for authorised users
Literature
1.
go back to reference NCCN Clinical Practice Guidelines in Oncology: Breast Cancer guideline–version 2. 2011, Washington, USA: National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology: Breast Cancer guideline–version 2. 2011, Washington, USA: National Comprehensive Cancer Network
2.
go back to reference Schiech L: Malignant cutaneous wounds. Clin J Oncol Nurs. 2002, 6: 305-309. 10.1188/02.CJON.305-309.CrossRefPubMed Schiech L: Malignant cutaneous wounds. Clin J Oncol Nurs. 2002, 6: 305-309. 10.1188/02.CJON.305-309.CrossRefPubMed
3.
go back to reference McDonald A, Lesage P: Palliative management of pressure ulcers and malignant wounds in patients with advanced illness. J Palliat Med. 2006, 9: 285-295. 10.1089/jpm.2006.9.285.CrossRefPubMed McDonald A, Lesage P: Palliative management of pressure ulcers and malignant wounds in patients with advanced illness. J Palliat Med. 2006, 9: 285-295. 10.1089/jpm.2006.9.285.CrossRefPubMed
4.
go back to reference Maida V, Ennis M, Kuziemsky C, Trozzolo L: Symptoms associated with malignant wounds: a prospective case series. J Pain Symptom Manage. 2009, 37: 206-211. 10.1016/j.jpainsymman.2008.01.009.CrossRefPubMed Maida V, Ennis M, Kuziemsky C, Trozzolo L: Symptoms associated with malignant wounds: a prospective case series. J Pain Symptom Manage. 2009, 37: 206-211. 10.1016/j.jpainsymman.2008.01.009.CrossRefPubMed
5.
go back to reference Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann H, Kelleners-Smeets NW: Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol. 2008, 9: 1149-1156. 10.1016/S1470-2045(08)70260-2.CrossRefPubMed Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann H, Kelleners-Smeets NW: Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol. 2008, 9: 1149-1156. 10.1016/S1470-2045(08)70260-2.CrossRefPubMed
6.
go back to reference Skelton LA: The effective treatment of basal cell carcinoma. Br J Nurs. 2009, 18: 348-350. Skelton LA: The effective treatment of basal cell carcinoma. Br J Nurs. 2009, 18: 348-350.
7.
go back to reference Kakimoto M, Tokita H, Okamura T, Yoshino K: A chemical hemostatic technique for bleeding from malignant wounds. J Palliat Med. 2010, 13: 11-13. 10.1089/jpm.2009.0238.CrossRefPubMed Kakimoto M, Tokita H, Okamura T, Yoshino K: A chemical hemostatic technique for bleeding from malignant wounds. J Palliat Med. 2010, 13: 11-13. 10.1089/jpm.2009.0238.CrossRefPubMed
8.
go back to reference Mohs FE, Sevringhaus EL, Schmidt ER: Conservative amputation of gangrenous parts by chemosurgery. Ann Surg. 1941, 114: 274-282. 10.1097/00000658-194108000-00011.CrossRefPubMedPubMedCentral Mohs FE, Sevringhaus EL, Schmidt ER: Conservative amputation of gangrenous parts by chemosurgery. Ann Surg. 1941, 114: 274-282. 10.1097/00000658-194108000-00011.CrossRefPubMedPubMedCentral
9.
go back to reference Mohs FE: Chemosurgical treatment of tumors of the parotid gland: a microscopically controlled method of excision. Ann Surg. 1949, 129: 381-393. 10.1097/00000658-194903000-00010.CrossRefPubMedPubMedCentral Mohs FE: Chemosurgical treatment of tumors of the parotid gland: a microscopically controlled method of excision. Ann Surg. 1949, 129: 381-393. 10.1097/00000658-194903000-00010.CrossRefPubMedPubMedCentral
10.
11.
go back to reference Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology; College of American Pathologists: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007, 25: 118-145.CrossRefPubMed Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF: American Society of Clinical Oncology; College of American Pathologists: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007, 25: 118-145.CrossRefPubMed
12.
go back to reference Dowsett C: Managing wound exudate: role of Versiva XC gelling foam dressing. Br J Nurs. 2008, 17: S38-S40–42.CrossRefPubMed Dowsett C: Managing wound exudate: role of Versiva XC gelling foam dressing. Br J Nurs. 2008, 17: S38-S40–42.CrossRefPubMed
13.
go back to reference Parish LC, Dryjski M, Cadden S: Prospective clinical study of a new adhesive gelling foam dressing in pressure ulcers. Int Wound J. 2008, 5: 60-67. 10.1111/j.1742-481X.2007.00428.x.CrossRefPubMed Parish LC, Dryjski M, Cadden S: Prospective clinical study of a new adhesive gelling foam dressing in pressure ulcers. Int Wound J. 2008, 5: 60-67. 10.1111/j.1742-481X.2007.00428.x.CrossRefPubMed
14.
go back to reference Daniels S, Sibbald RG, Ennis W, Eager CA: Evaluation of a new composite dressing for the management of chronic leg ulcer wounds. J Wound Care. 2002, 11: 290-294.CrossRefPubMed Daniels S, Sibbald RG, Ennis W, Eager CA: Evaluation of a new composite dressing for the management of chronic leg ulcer wounds. J Wound Care. 2002, 11: 290-294.CrossRefPubMed
15.
go back to reference Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R: Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005, 53: 253-260. 10.1016/j.jaad.2005.02.059.CrossRefPubMed Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R: Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005, 53: 253-260. 10.1016/j.jaad.2005.02.059.CrossRefPubMed
16.
go back to reference Rowe DE, Carroll RJ, Day CL: Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992, 26: 976-990. 10.1016/0190-9622(92)70144-5.CrossRefPubMed Rowe DE, Carroll RJ, Day CL: Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992, 26: 976-990. 10.1016/0190-9622(92)70144-5.CrossRefPubMed
Metadata
Title
Locally advanced breast cancer made amenable to radical surgery after a combination of systemic therapy and Mohs paste: two case reports
Authors
Tomoya Tsukada
Tatsuo Nakano
Miki Matoba
Daisuke Matsui
Shozo Sasaki
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2012
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-6-360

Other articles of this Issue 1/2012

Journal of Medical Case Reports 1/2012 Go to the issue